|
1
|
Riihimäki M, Thomsen H, Sundquist K,
Sundquist J and Hemminki K: Clinical landscape of cancer
metastases. Cancer Med. 7:5534–5542. 2018.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Yu B, Yan L, Wang H and Yang J and Yang J:
Invasive lobular carcinoma of the breast: Metastatic patterns and
treatment modalities-a review. Front Oncol.
15(1631670)2025.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Bhaludin BN, Tunariu N, Koh DM, Messiou C,
Okines AF, McGrath SE, Ring AE, Parton MM, Sharma B, Gagliardi T,
et al: A review on the added value of whole-body MRI in metastatic
lobular breast cancer. Eur Radiol. 32:6514–6525. 2022.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Inoue M, Nakagomi H, Nakada H, Furuya K,
Ikegame K, Watanabe H, Omata M and Oyama T: Specific sites of
metastases in invasive lobular carcinoma: A retrospective cohort
study of metastatic breast cancer. Breast Cancer. 24:667–672.
2017.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Sledge GW Jr, Toi M, Neven P, Sohn J,
Inoue K, Pivot X, Burdaeva O, Okera M, Masuda N, Kaufman PA, et al:
MONARCH 2: Abemaciclib in combination with fulvestrant in women
with HR+/HER2- advanced breast cancer who had progressed while
receiving endocrine therapy. J Clin Oncol. 35:2875–2884.
2017.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Hortobagyi GN, Stemmer SM, Burris HA, Yap
YS, Sonke GS, Paluch-Shimon S, Campone M, Blackwell KL, André F,
Winer EP, et al: Ribociclib as first-line therapy for HR-positive,
advanced breast cancer. N Engl J Med. 375:1738–1748.
2016.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Edge SB and Compton CC: The American joint
committee on cancer: The 7th edition of the AJCC cancer staging
manual and the future of TNM. Ann Surg Oncol. 17:1471–1474.
2010.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Oken MM, Creech RH, Tormey DC, Horton J,
Davis TE, McFadden ET and Carbone PP: Toxicity and response
criteria of the Eastern cooperative oncology group. Am J Clin
Oncol. 5:649–655. 1982.PubMed/NCBI
|
|
9
|
Nazareno J, Taves D and Preiksaitis HG:
Metastatic breast cancer to the gastrointestinal tract: A case
series and review of the literature. World J Gastroenterol.
12:6219–6224. 2006.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Mikuła-Pietrasik J, Uruski P, Tykarski A
and Książek K: The peritoneal ‘soil’ for a cancerous ‘seed’: A
comprehensive review of the pathogenesis of intraperitoneal cancer
metastases. Cell Mol Life Sci. 75:509–525. 2018.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Schwarz RE, Klimstra DS and Turnbull AD:
Metastatic breast cancer masquerading as gastrointestinal primary.
Am J Gastroenterol. 93:111–114. 1998.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Zhou G, Li A and Wang R: The role of IL-17
family in the process of pulmonary fibrosis. Life Conflux: Jun 30,
2025 (Epub ahead of print).
|
|
13
|
Liebig C, Ayala G, Wilks JA, Berger DH and
Albo D: Perineural invasion in cancer: A review of the literature.
Cancer. 115:3379–3391. 2009.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Wang TH, Angeli TR, Ishida S, Du P,
Gharibans A, Paskaranandavadivel N, Imai Y, Miyagawa T, Abell TL,
Farrugia G, et al: The influence of interstitial cells of Cajal
loss and aging on slow wave conduction velocity in the human
stomach. Physiol Rep. 8(e14659)2021.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Mantovani A, Allavena P, Sica A and
Balkwill F: Cancer-related inflammation. Nature. 454:436–444.
2008.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Villa Guzmán JC, Espinosa J, Cervera R,
Delgado M, Patón R and Cordero García JM: Gastric and colon
metastasis from breast cancer: Case report, review of the
literature, and possible underlying mechanisms. Breast Cancer (Dove
Med Press). 9:1–7. 2016.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Thill M and Schmidt M: Management of
adverse events during cyclin-dependent kinase 4/6 (CDK4/6)
inhibitor-based treatment in breast cancer. Ther Adv Med Oncol: Sep
3, 2018 (Epub ahead of print).
|
|
18
|
Onesti CE and Jerusalem G: CDK4/6
inhibitors in breast cancer: Differences in toxicity profiles and
impact on agent choice. A systematic review and meta-analysis.
Expert Rev Anticancer Ther. 21:283–298. 2021.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Braal CL, Jongbloed EM, Wilting SM,
Mathijssen RHJ, Koolen SLW and Jager A: Inhibiting CDK4/6 in breast
cancer with palbociclib, ribociclib, and abemaciclib: Similarities
and differences. Drugs. 81:317–331. 2021.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Cardoso F, Paluch-Shimon S, Senkus E,
Curigliano G, Aapro MS, André F, Barrios CH, Bergh J, Bhattacharyya
GS, Biganzoli L, et al: 5th ESO-ESMO international consensus
guidelines for advanced breast cancer (ABC 5). Ann Oncol.
31:1623–1649. 2020.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Li T, Jiang X, Zhang Z, Chen X, Wang J,
Zhao X and Zhang J: Case report: 68Ga-FAPI PET/CT, a
more advantageous detection mean of gastric, peritoneal, and
ovarian metastases from breast cancer. Front Oncol 12:1013066,
2022.
|
|
22
|
Somuncu E, Topal Ü, Sönmez S, Kara Y,
Bozdağ E, Özcan A, Başaran C, Özkan C, Tatlıdil YE and Kalaycı MU:
Incidentally detected gastrointestinal wall thickness on abdominal
computed tomography; What does it mean for endoscopy? Arch Iran
Med. 24:296–300. 2021.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Cai Q, Baumgarten DA, Affronti JP and
Waring JP: Incidental findings of thickening luminal
gastrointestinal organs on computed tomography: An absolute
indication for endoscopy. Am J Gastroenterol. 98:1734–1737.
2003.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Bleibel W, Guerrero JE, Kim S, Leao L,
Ghosh T and Kenney TJ Jr: The clinical significance of incidental
computer tomography finding of gastrointestinal luminal wall
thickening as evaluated by endoscopy. Dig Dis Sci. 52:1709–1712.
2007.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Tellez-Avila FI, García-Osogobio S,
Chavez-Tapia NC, Ramirez-Luna MA, Franco-Guzman A, Sosa-Lozano A
and Giovannini M: Utility of endoscopy in patients with incidental
gastrointestinal luminal wall thickening detected with CT. Surg
Endosc. 23:2191–2196. 2009.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Hathi DK and Jones EF: 68Ga
FAPI PET/CT: Tracer uptake in 28 different kinds of cancer. Radiol
Imaging Cancer. 1(e194003)2019.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Taal BG, Peterse H and Boot H: Clinical
presentation, endoscopic features, and treatment of gastric
metastases from breast carcinoma. Cancer. 89:2214–2221.
2000.PubMed/NCBI
|
|
28
|
De Palma GD, Masone S, Rega M, Simeoli I,
Donisi M, Addeo P, Iannone L, Pilone V and Persico G: Metastatic
tumors to the stomach: Clinical and endoscopic features. World J
Gastroenterol. 12:7326–7328. 2006.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Miettinen M, McCue PA, Sarlomo-Rikala M,
Rys J, Czapiewski P, Wazny K, Langfort R, Waloszczyk P, Biernat W,
Lasota J and Wang Z: GATA3: A multispecific but potentially useful
marker in surgical pathology: A systematic analysis of 2500
epithelial and nonepithelial tumors. Am J Surg Pathol. 38:13–22.
2014.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Shield PW, Papadimos DJ and Walsh MD:
GATA3: A promising marker for metastatic breast carcinoma in serous
effusion specimens. Cancer Cytopathol. 122:307–312. 2014.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Kusunoki C, Hamakawa T, Mano M, Nishikawa
K, Toshiyama R, Miyo M, Fujiwara A, Miyake M, Hama N, Miyamoto A,
et al: A case of advanced gastric cancer with umbilical metastasis,
pyloric stenosis, and peritoneal dissemination underwent palliative
surgery after chemotherapy. Gan To Kagaku Ryoho. 47:513–515.
2020.PubMed/NCBI(In Japanese).
|
|
32
|
Satoh E, Yatabe Y, Uehira D, Yonekura K,
Murakata A, Toyofuku Y, Tanami H, Osanai T, Sugano N, Sakoma T and
Maruyama S: A case of pyloric stenosis due to gastric metastasis of
breast cancer. Gan To Kagaku Ryoho. 48:2103–2105. 2021.PubMed/NCBI(In Japanese).
|
|
33
|
Troncone E, Fugazza A, Cappello A, Del
Vecchio Blanco G, Monteleone G, Repici A, Teoh AYB and Anderloni A:
Malignant gastric outlet obstruction: Which is the best therapeutic
option? World J Gastroenterol. 26:1847–1860. 2020.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Beniey M: Peritoneal metastases from
breast cancer: A scoping review. Cureus. 11(e5367)2019.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Tsujimura K, Teruya T, Kiyuna M, Higa K,
Higa J, Iha K, Chinen K, Asato M, Takushi Y, Ota M, et al: Colonic
metastasis from breast carcinoma: A case report. World J Surg
Oncol. 15(124)2017.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Cardi M, Sammartino P, Framarino ML,
Biacchi D, Cortesi E, Sibio S, Accarpio F, Luciani C, Palazzo A and
di Giorgio A: Treatment of peritoneal carcinomatosis from breast
cancer by maximal cytoreduction and HIPEC: A preliminary report on
5 cases. Breast. Oktober. 22:845–849. 2013.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Cardi M, Sammartino P, Mingarelli V, Sibio
S, Accarpio F, Biacchi D, Musio D, Sollazzo B and Di Giorgio A:
Cytoreduction and HIPEC in the treatment of ‘unconventional’
secondary peritoneal carcinomatosis. World J Surg Oncol.
13(305)2015.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Yu JH, Feng Y, Li XB, Zhang CY, Shi F, An
SL, Liu G, Zhang YB, Zhang K, Ji ZH, et al: Cytoreductive surgery
and hyperthermic intraperitoneal chemotherapy for peritoneal
metastasis from breast cancer: A preliminary report of 4 cases.
Gland Surg. 10:1315–1324. 2021.PubMed/NCBI View Article : Google Scholar
|
